PMID: 20629311Jul 16, 2010Paper

The change of CD4+ CD25high CCR6+ regulatory T cells in breast cancer patients

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Lin XuXian-Ying Tang

Abstract

To detect the proportion of CD4+ CD25high CCR6+ regulatory T cells in peripheral blood mononuclear cells and tumor infiltration lymphocytes from breast cancer patients and explore its significance. Lymphocytes isolated from blood and tumor mass of breast cancer patients were analyzed for the proportion of CD4+ CD25high CCR6+ regulatory T cells by flow cytometry. The expression of Foxp3 on CD4+ CD25high CCR6+ regulatory T cells, as well as CD45RO, CD44 and CD62L, were also analyzed. The effects of CD4+ CD25high CCR6+ regulatory T cells on the proliferation of CD4+ CD25- T cells also were detected by 3H-incorporation assay. Compared to the control, increased proportion of CD4+ CD25high CCR6+ regulatory T cells was observed in PBMCs and TILs from breast cancer patients. Moreover, CD4+ CD25high CCR6+ regulatory T cells, expressing high level of Foxp3, displayed effector memory phenotype determined by high level expression of CD45RO, CD44 and low level of CD62L. In addition, CD4+ CD25high CCR6+ regulatory T cells could inhibit the proliferation of CD4+ CD25- T cells in vitro. The enrichment of CD4+ CD25high CCR6+ regulatory T cells in tumor mass in breast cancer patients, which might be close related to long term immunoescape of tumor.

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.